PET-CT en pacientes con cáncer de pulmón

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.

https://doi.org/10.3322/canjclin.55.2.74

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2006 database: fast stats [Internet]. Lyon, France: International Agency for Research on Cancer 2010 [Citado: 10 julio 2010]. Disponible en: http://globocan.iarc,fr/factsheets/populations/factsheet.asp,2006.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.

https://doi.org/10.3322/CA.2007.0010

Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER- Medicare data. Med Care. 2002;40(8 Suppl):IV-104-17.

https://doi.org/10.1097/00005650-200208001-00014

Colombia, Departamento Administrativo Nacional de Estadística. Estadísticas Vitales-Defunciones no fetales. [Internet] Bogotá: DANE; 2006 [Citado: 20 enero 2010]. Disponible en: http://www.dane.gov.co/les/investigaciones/poblacion/defunciones/defun_2007/CUADRO5.xls.

Piñeros M, Murillo R. Incidencia de cáncer en Colombia: importancia de las fuentes de información en la obtención de cifras estimativas. Rev Colomb Cancerol. 2004;8(1):5-14.

Poland, Agency for Health Technology Assessment in Poland. Cost-effectiveness analysis of PET-CT positron emission tomography and the diagnostic technologies financed from public sources in oncological diagnostic in Poland. Clinical and epidemiological aspects. Warszawa-Nowy Sacz, Agency for Health Technology Assessment in Poland; 2006.

Alberg AJ, Ford JG, Samet JM; American College of Chest Physicians. Epidemiology of Lung Cancer: ACCP eviden-ce-based clinical practice guidelines (2nd dition). Chest. 2007;132(3 Suppl):29S-55S. Review.

https://doi.org/10.1378/chest.07-1347

Colombia, Instituto Nacional de Cancerología. Registro Institucional de Cáncer. En: Anuario Estadístico 2007. Bogotá: INC; 2008. p. 10-55.

Colombia, Instituto Nacional de Cancerología. Registro Institucional de Cáncer. En: Anuario Estadístico 2008. Bogotá: INC; 2009. p. 10-55.

España, Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Agencia de Evaluación de Tecnologías Sanitarias. PET-TAC: Indicaciones, revisión sistemática y meta-análisis. Madrid: Agencia de Evaluación de Tecnologías Sanitarias; 2004.

Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007;11(44):iii.iv, xi-267.

https://doi.org/10.3310/hta11440

Senan S, De Ruysscher D. Critical review of PET-CT for radiotherapy planning in lung cancer. Crit Rev Oncol Hematol. 2005;56(3):345-51.

https://doi.org/10.1016/j.critrevonc.2005.05.001

Freudenberg LS, Rosenbaum SJ, Beyer T, Bockisch A, Antoch G. PET versus PET/CT dual-modality imaging in evaluation of lung cancer. Thorac Surg Clin. 2010;20(1):25-30.

https://doi.org/10.1016/j.thorsurg.2009.12.003

Truong MT, Munden RF, Movsas B. Imaging to optimally stage lung cancer: conventional modalities and PET/CT. J Am Coll Radiol. 2004;1(12):957-64.

https://doi.org/10.1016/j.jacr.2004.07.007

Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48 Suppl l:78S-88S.

Sachelarie I, Kerr K, Ghesani M, Blum RH. Integrated PET-CT: evidence-based review of oncology indications. Oncology. 2005;19(4):481-90.

Podoloff DA, Advani RH, Allred C, Benson AB 3rd, Brown E, Burstein HJ, et al. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw. 2007;5Suppl 1:S1-S22.

Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology. 2003;229(2):526-33.

https://doi.org/10.1148/radiol.2292021598

Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348(25):2500-7.

https://doi.org/10.1056/NEJMoa022136

Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236(3):1011-9.

https://doi.org/10.1148/radiol.2363041310

Cerfolio RJ, Bryant AS, Ojha B, Eloubeidi M. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg. 2005;80(4):1207-14.

https://doi.org/10.1016/j.athoracsur.2005.04.019

Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004;78(3):1017-23.

https://doi.org/10.1016/j.athoracsur.2004.02.067

Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med. 2004;45(10):1640-6.

Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001; 285(7):914-24.

https://doi.org/10.1001/jama.285.7.914

National Collamorating Centre for Acuete Care, The Diagnosis and Treatment of Lung Cancer. Methods, evidence and guidance. 2005. [Internet]. London: The Royal College of Surgeons of England [Citado: 20 enero 2010]. Disponible en: http://www.nice.org.uk/nicemedia/pdf/cg024fullguideline.pdf

Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? Eur J Nucl Med. 1998;25(11):1495-501.

https://doi.org/10.1007/s002590050327

Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290(24):3199-206.

https://doi.org/10.1001/jama.290.24.3199

Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol. 2003;90(3):519-28.

https://doi.org/10.1016/S0090-8258(03)00336-6

Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology. 2002;225(2):575-81.

https://doi.org/10.1148/radiol.2252011568

Cleemput I, Dargent G, Poelmans J, Camberlin C, Van den Bruel A, Ramaekers D. HTA positron emission tomography in Belgium. KCE Reports Vol. 22C. Brussels: Centre Federal d'Expertise des Soins de Santé; 2005.